speb/financial-data huggingface dataset:
NIVF cash_flow (annual, 2023-12-31) — Taxes Refund Paid: 0.00
NIVF balance_sheet (annual, 2023-12-31) — Total Assets: 4486996.00
NIVF balance_sheet (annual, 2023-12-31) — Total Capitalization: 3735612.00
NIVF balance_sheet (annual, 2023-12-31) — Total Debt: 332553.00
NIVF balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3245561.00
NIVF income_statement (annual, 2023-12-31) — Total Expenses: 5093911.00
NIVF balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1241435.00
NIVF balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2028160.00
NIVF balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 118979.00
NIVF income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 42242.00
NIVF balance_sheet (annual, 2023-12-31) — Total Tax Payable: 494055.00
NIVF income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
NIVF income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
NIVF balance_sheet (annual, 2023-12-31) — Working Capital: 1336380.00
NIVF income_statement (quarterly, 2024-09-30) — +Operating Expense: 432516.00
NIVF income_statement (quarterly, 2024-09-30) — +Total Revenue: 1472861.00
NIVF income_statement (quarterly, 2024-09-30) — Cost Of Revenue: 824034.00
NIVF income_statement (quarterly, 2024-09-30) — Diluted NI Availto Com Stockholders: -19857.00
NIVF income_statement (quarterly, 2024-09-30) — EBIT: 207047.00
NIVF income_statement (quarterly, 2024-09-30) — EBITDA: 207047.00
NIVF income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 296972.00
NIVF income_statement (quarterly, 2024-09-30) — Gross Profit: 648827.00
NIVF income_statement (quarterly, 2024-09-30) — Interest Expense: 237389.00
NIVF income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 237389.00
NIVF income_statement (quarterly, 2024-09-30) — Interest Income: -10522.00
NIVF income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: -10522.00
NIVF income_statement (quarterly, 2024-09-30) — Minority Interests: 10485.00
NIVF income_statement (quarterly, 2024-09-30) — Net Income: -19857.00
NIVF income_statement (quarterly, 2024-09-30) — Net Income Common Stockholders: -19857.00
NIVF income_statement (quarterly, 2024-09-30) — Net Income Continuous Operations: -30342.00
NIVF income_statement (quarterly, 2024-09-30) — Net Income From Continuing And Discontinued Operation: -19857.00
NIVF income_statement (quarterly, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: -19857.00
NIVF income_statement (quarterly, 2024-09-30) — Net Income Including Noncontrolling Interests: -30342.00
NIVF income_statement (quarterly, 2024-09-30) — Net Interest Income: -247911.00
NIVF income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: -247911.00
NIVF income_statement (quarterly, 2024-09-30) — Normalized EBITDA: 207047.00
NIVF income_statement (quarterly, 2024-09-30) — Normalized Income: -19857.00
NIVF income_statement (quarterly, 2024-09-30) — Operating Income: 216311.00
NIVF income_statement (quarterly, 2024-09-30) — Operating Revenue: 1472861.00
NIVF income_statement (quarterly, 2024-09-30) — Other Gand A: 296972.00
NIVF income_statement (quarterly, 2024-09-30) — Other Income Expense: 1258.00
NIVF income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 1258.00
NIVF income_statement (quarterly, 2024-09-30) — Pretax Income: -30342.00
NIVF income_statement (quarterly, 2024-09-30) — Reconciled Cost Of Revenue: 824034.00
NIVF income_statement (quarterly, 2024-09-30) — Selling And Marketing Expense: 135544.00
NIVF income_statement (quarterly, 2024-09-30) — Selling General And Administration: 432516.00
NIVF income_statement (quarterly, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
NIVF income_statement (quarterly, 2024-09-30) — Tax Provision: 0.00
NIVF income_statement (quarterly, 2024-09-30) — Tax Rate For Calcs: 0.00
NIVF income_statement (quarterly, 2024-09-30) — Total Expenses: 1256550.00
NIVF income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: 216311.00
NIVF income_statement (annual, 2024-12-31) — +Operating Expense: 2987389.00
NIVF income_statement (quarterly, 2024-12-31) — +Operating Expense: 1628255.00
NIVF income_statement (annual, 2024-12-31) — +Total Revenue: 5433375.00
NIVF income_statement (quarterly, 2024-12-31) — +Total Revenue: 1273612.00
NIVF balance_sheet (annual, 2024-12-31) — Accounts Payable: 1298964.00
NIVF balance_sheet (annual, 2024-12-31) — Accounts Receivable: 49245.00
NIVF balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1239320.00
NIVF balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 122505.00
NIVF balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -19.00
NIVF cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
NIVF income_statement (annual, 2024-12-31) — Basic Average Shares: 126.00
NIVF income_statement (annual, 2024-12-31) — Basic EPS: -4163.83
NIVF cash_flow (annual, 2024-12-31) — Beginning Cash Position: 54104.00
NIVF balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 196929.00
NIVF cash_flow (annual, 2024-12-31) — Capital Expenditure: -53045.00
NIVF balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 118757.00
NIVF balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 457740.00
NIVF balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 457740.00
NIVF cash_flow (annual, 2024-12-31) — Cash Dividends Paid: 0.00
NIVF cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 8675790.00
NIVF cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -53045.00
NIVF cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -8264074.00
NIVF cash_flow (annual, 2024-12-31) — Change In Account Payable: 1126338.00
NIVF cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -6750587.00
NIVF cash_flow (annual, 2024-12-31) — Change In Inventory: 45451.00
NIVF cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -204846.00
NIVF cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 55552.00
NIVF cash_flow (annual, 2024-12-31) — Change In Payable: 1126338.00
NIVF cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -5624249.00
NIVF cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -2000851.00
NIVF cash_flow (annual, 2024-12-31) — Change In Receivables: -39871.00
NIVF cash_flow (annual, 2024-12-31) — Change In Working Capital: -7768814.00
NIVF cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -39871.00
NIVF cash_flow (annual, 2024-12-31) — Changes In Cash: 358671.00
NIVF balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Common Stock Equity: -1048614.00
NIVF cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
NIVF income_statement (annual, 2024-12-31) — Cost Of Revenue: 3606481.00
NIVF income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 734477.00
NIVF balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 201455.00
NIVF balance_sheet (annual, 2024-12-31) — Current Assets: 3172745.00
NIVF balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 108526.00
NIVF balance_sheet (annual, 2024-12-31) — Current Debt: 582447.00
NIVF balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 690973.00
NIVF balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 69838.00
NIVF balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 69838.00
NIVF balance_sheet (annual, 2024-12-31) — Current Liabilities: 2720354.00
NIVF balance_sheet (annual, 2024-12-31) — Current Notes Payable: 500000.00
NIVF cash_flow (annual, 2024-12-31) — Deferred Income Tax: -486706.00
NIVF cash_flow (annual, 2024-12-31) — Deferred Tax: -486706.00
NIVF cash_flow (annual, 2024-12-31) — Depreciation: 206264.00
NIVF cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 206264.00
NIVF cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 206264.00
NIVF income_statement (annual, 2024-12-31) — Diluted Average Shares: 126.00
NIVF income_statement (annual, 2024-12-31) — Diluted EPS: -4163.83
NIVF income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -524643.00
NIVF income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -108243.00
NIVF balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 154453.00
NIVF income_statement (annual, 2024-12-31) — EBIT: -182151.00
NIVF income_statement (quarterly, 2024-12-31) — EBIT: -121579.00
NIVF income_statement (annual, 2024-12-31) — EBITDA: 24113.00
NIVF income_statement (quarterly, 2024-12-31) — EBITDA: -121579.00
NIVF cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 44965.00
NIVF cash_flow (annual, 2024-12-31) — End Cash Position: 457740.00
NIVF cash_flow (annual, 2024-12-31) — Financing Cash Flow: 8675790.00
NIVF balance_sheet (annual, 2024-12-31) — Finished Goods: 80813.00
NIVF cash_flow (annual, 2024-12-31) — Free Cash Flow: -8317119.00
NIVF cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -953861.00
NIVF cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
NIVF cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 18875.00
NIVF income_statement (annual, 2024-12-31) — General And Administrative Expense: 2781075.00
NIVF income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 1614217.00
NIVF balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
NIVF balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 49264.00
NIVF balance_sheet (annual, 2024-12-31) — Gross PPE: 1610986.00
NIVF income_statement (annual, 2024-12-31) — Gross Profit: 1826894.00
NIVF income_statement (quarterly, 2024-12-31) — Gross Profit: 539135.00
NIVF cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
NIVF income_statement (annual, 2024-12-31) — Interest Expense: 778656.00
NIVF income_statement (quarterly, 2024-12-31) — Interest Expense: 421105.00
NIVF income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 778656.00
NIVF income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 421105.00
NIVF income_statement (annual, 2024-12-31) — Interest Income: 6953.00
NIVF income_statement (quarterly, 2024-12-31) — Interest Income: 4554.00
NIVF income_statement (annual, 2024-12-31) — Interest Income Non Operating: 6953.00
NIVF income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 4554.00
NIVF cash_flow (annual, 2024-12-31) — Interest Paid Cff: -677663.00
NIVF cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 677663.00
NIVF balance_sheet (annual, 2024-12-31) — Inventory: 80813.00
NIVF balance_sheet (annual, 2024-12-31) — Invested Capital: 1862749.00
NIVF cash_flow (annual, 2024-12-31) — Investing Cash Flow: -53045.00
NIVF cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
NIVF cash_flow (annual, 2024-12-31) — Issuance Of Debt: 8583597.00
NIVF balance_sheet (annual, 2024-12-31) — Loans Receivable: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 10231.00
NIVF balance_sheet (annual, 2024-12-31) — Long Term Debt: 2328916.00
NIVF balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2339147.00
NIVF cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 8583597.00
NIVF cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -6446.00
NIVF balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 529711.00
NIVF balance_sheet (annual, 2024-12-31) — Minority Interest: -433143.00
NIVF income_statement (annual, 2024-12-31) — Minority Interests: -50542.00
NIVF income_statement (quarterly, 2024-12-31) — Minority Interests: -52265.00
NIVF cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
NIVF cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Net Debt: 2453623.00
NIVF income_statement (annual, 2024-12-31) — Net Income: -524643.00
NIVF income_statement (quarterly, 2024-12-31) — Net Income: -108243.00
NIVF income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -524643.00
NIVF income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -108243.00
NIVF income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -474101.00
NIVF income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -55978.00
NIVF income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -524643.00
NIVF income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -108243.00
NIVF income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -524643.00
NIVF income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -108243.00
NIVF cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -474101.00
NIVF income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -474101.00
NIVF income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -55978.00
NIVF cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
NIVF income_statement (annual, 2024-12-31) — Net Interest Income: -771703.00
NIVF income_statement (quarterly, 2024-12-31) — Net Interest Income: -416551.00
NIVF cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
NIVF cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 8577151.00
NIVF cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 8577151.00
NIVF income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -771703.00
NIVF income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -416551.00
NIVF cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 776302.00
NIVF balance_sheet (annual, 2024-12-31) — Net PPE: 371666.00
NIVF cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -53045.00
NIVF cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -1048614.00
NIVF balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 33333.00
NIVF income_statement (annual, 2024-12-31) — Normalized EBITDA: 24113.00
NIVF income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -121579.00
NIVF income_statement (annual, 2024-12-31) — Normalized Income: -524643.00
NIVF income_statement (quarterly, 2024-12-31) — Normalized Income: -108243.00
NIVF cash_flow (annual, 2024-12-31) — Operating Cash Flow: -8264074.00
NIVF cash_flow (annual, 2024-12-31) — Operating Gains Losses: -953861.00
NIVF income_statement (annual, 2024-12-31) — Operating Income: -1160495.00
NIVF income_statement (quarterly, 2024-12-31) — Operating Income: -1089120.00
NIVF income_statement (annual, 2024-12-31) — Operating Revenue: 5433375.00
NIVF income_statement (quarterly, 2024-12-31) — Operating Revenue: 1273612.00
NIVF balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 126.00
NIVF balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 126.00
NIVF balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 82447.00
NIVF balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 18875.00
NIVF balance_sheet (annual, 2024-12-31) — Other Equity Interest: -204000.00
NIVF income_statement (annual, 2024-12-31) — Other Gand A: 2781075.00
NIVF income_statement (quarterly, 2024-12-31) — Other Gand A: 1614217.00
NIVF income_statement (annual, 2024-12-31) — Other Income Expense: 971391.00
NIVF income_statement (quarterly, 2024-12-31) — Other Income Expense: 962987.00
NIVF cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1201398.00
NIVF income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 971391.00
NIVF income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 962987.00
NIVF balance_sheet (annual, 2024-12-31) — Other Payable: 288564.00
NIVF balance_sheet (annual, 2024-12-31) — Other Properties: 884346.00
NIVF balance_sheet (annual, 2024-12-31) — Other Receivables: 1313328.00
NIVF balance_sheet (annual, 2024-12-31) — Payables: 1758088.00
NIVF balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1959543.00
NIVF balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1271623.00
NIVF income_statement (annual, 2024-12-31) — Pretax Income: -960807.00
NIVF income_statement (quarterly, 2024-12-31) — Pretax Income: -542684.00
NIVF balance_sheet (annual, 2024-12-31) — Properties: 0.00
NIVF cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 0.00
NIVF cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
NIVF cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
NIVF cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
NIVF cash_flow (annual, 2024-12-31) — Purchase Of PPE: -53045.00
NIVF balance_sheet (annual, 2024-12-31) — Receivables: 1362569.00
NIVF balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -4.00
NIVF income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 3606481.00
NIVF income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 734477.00
NIVF income_statement (annual, 2024-12-31) — Reconciled Depreciation: 206264.00
NIVF cash_flow (annual, 2024-12-31) — Repayment Of Debt: -6446.00
NIVF income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Retained Earnings: -985994.00
NIVF income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 206314.00
NIVF income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 14038.00
NIVF income_statement (annual, 2024-12-31) — Selling General And Administration: 2987389.00
NIVF income_statement (quarterly, 2024-12-31) — Selling General And Administration: 1628255.00
NIVF balance_sheet (annual, 2024-12-31) — Share Issued: 126.00
NIVF balance_sheet (quarterly, 2024-12-31) — Share Issued: 126.00
NIVF cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
NIVF income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Stockholders Equity: -1048614.00
NIVF balance_sheet (annual, 2024-12-31) — Tangible Book Value: -1048614.00
NIVF income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
NIVF income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
NIVF income_statement (annual, 2024-12-31) — Tax Provision: -486706.00
NIVF income_statement (quarterly, 2024-12-31) — Tax Provision: -486706.00
NIVF income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.10
NIVF income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.10
NIVF cash_flow (annual, 2024-12-31) — Taxes Refund Paid: 11746.00
NIVF balance_sheet (annual, 2024-12-31) — Total Assets: 3577744.00
NIVF balance_sheet (annual, 2024-12-31) — Total Capitalization: 1280302.00
NIVF balance_sheet (annual, 2024-12-31) — Total Debt: 3030120.00
NIVF balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -1481757.00
NIVF income_statement (annual, 2024-12-31) — Total Expenses: 6593870.00
NIVF income_statement (quarterly, 2024-12-31) — Total Expenses: 2362732.00
NIVF balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 5059501.00
NIVF balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 404999.00
NIVF balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2339147.00
NIVF income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -1160495.00
NIVF income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -1089120.00
NIVF balance_sheet (annual, 2024-12-31) — Total Tax Payable: 16107.00
NIVF income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
NIVF income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
NIVF balance_sheet (annual, 2024-12-31) — Working Capital: 452391.00
NIVF balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 8153.00
NIVF balance_sheet (quarterly, 2025-06-30) — Share Issued: 8153.00
NIVF income_statement (quarterly, 2025-09-30) — +Operating Expense: 2630508.00
NIVF income_statement (quarterly, 2025-09-30) — +Total Revenue: 1282251.00
NIVF balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 797718.00
NIVF balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 185907.00
NIVF balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 13063507.00
NIVF balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 262712.00
NIVF balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 603599.00
NIVF balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
NIVF balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 295289.00
NIVF balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 295289.00
NIVF balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
NIVF balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 29376132.00
NIVF income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1164234.00
NIVF balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 450341.00
NIVF balance_sheet (quarterly, 2025-09-30) — Current Assets: 5555874.00
NIVF balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 305518.00
NIVF balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 305518.00
NIVF balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 67401.00
NIVF balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 67401.00
NIVF balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1620978.00
NIVF balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 0.00
NIVF income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 16823355.00
NIVF balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 89973.00
NIVF balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 0.00
NIVF income_statement (quarterly, 2025-09-30) — EBIT: 16796075.00
NIVF income_statement (quarterly, 2025-09-30) — EBITDA: 16796075.00
NIVF balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -249711.00
NIVF income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2443296.00
NIVF balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 24242555.00
NIVF balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1175695.00
NIVF income_statement (quarterly, 2025-09-30) — Gross Profit: 118017.00
NIVF income_statement (quarterly, 2025-09-30) — Interest Expense: 48094.00
NIVF income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 48094.00